Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Posts falsely claim Netanyahu video fabricated to cover up his death - 2An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Youngsters
- 3Should you get an RSV vaccine this fall? What to know and where to get a shot
- 4Manual for Famous Beverages 2024
- 5Language Learning Applications for Voyagers
- Cuba fights to contain spread of mosquito-borne chikungunya virus
- Qantas and Virgin Australia Ban Power Bank Usage on Flights Following Safety Incidents
- Vote in favor of Your #1 Climbing boots Now
- Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
- 6 Famous Cell phone Brands All over The Planet
- Two separate Israeli espionage cases uncover Iran-linked activities in Jerusalem, Ashkelon
- Figure out How to Back Your Rooftop Substitution
- Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test
- 6 Robot Vacuum Cleaners for Easy Home Cleaning
